Verheugen C, Pardridge W M, Judd H L, Chaudhuri G
J Clin Endocrinol Metab. 1984 Dec;59(6):1128-32. doi: 10.1210/jcem-59-6-1128.
The role of capillary membrane permeability and the effect of plasma protein binding on the influx of unconjugated and conjugated estrogens into a target organ, the uterus, and a metabolic organ, the liver, were studied in anesthetized rats. In the absence of plasma proteins, estrone (E1) and estradiol (E2) were freely diffusible through the uterine capillaries, but influx was significantly reduced for estriol (E3) and estetrol. In the uterus, the influx of the conjugated estrogens was markedly restricted and approximated the influx of dextran, a vascular space marker. The polarity of the compound (based on the number of hydrogen bond-forming functional groups and the presence of charged groups) appeared to predict uterine endothelial membrane permeability better than the octanol/Ringer's partition coefficient. In contrast to the selective permeability properties of the uterine endothelial barrier, the limiting membrane lining the hepatic microcirculation, the hepatocyte cell membrane, was highly permeable to all unconjugated and conjugated estrogens. The addition of 4% albumin to the injection solution led to a significant inhibition of uterine influx of E2, but not E1 or E3. In the liver, only the influx of E1 sulfate was slightly diminished by 4% albumin. In all cases, the influx of estrogens greatly exceeded the rate that would be expected if only the fraction that was free (dialyzable) in vitro was diffusible in vivo. Human sera containing sex hormone-binding globulin and albumin caused inhibition of influx of E1 and E2 through the uterine capillary barriers, whereas in the liver, the influx of E2 sulfate, and E3 glucuronide were diminished. The results are compatible with a difference in permeability of the microvasculature of the two organs and a differential availability of protein-bound estrogen for influx into liver and uterus. With the exception of E1, which is nearly completely diffusible into both organs, the influx of estrogens and estrogen conjugates into liver is greatly amplified compared to that into a peripheral organ such as the uterus.
在麻醉大鼠中研究了毛细血管膜通透性的作用以及血浆蛋白结合对未结合和结合雌激素流入靶器官子宫和代谢器官肝脏的影响。在没有血浆蛋白的情况下,雌酮(E1)和雌二醇(E2)可自由通过子宫毛细血管扩散,但雌三醇(E3)和雌四醇的流入量显著减少。在子宫中,结合雌激素的流入受到明显限制,接近血管空间标记物右旋糖酐的流入量。化合物的极性(基于形成氢键的官能团数量和带电基团的存在)似乎比辛醇/林格氏液分配系数更能预测子宫内皮细胞膜通透性。与子宫内皮屏障的选择性通透特性相反,肝微循环内衬的限制膜即肝细胞膜对所有未结合和结合雌激素都具有高度通透性。向注射溶液中添加4%白蛋白会导致E2子宫流入量显著抑制,但对E1或E3无此作用。在肝脏中,只有硫酸E1的流入量因4%白蛋白而略有减少。在所有情况下,雌激素的流入量大大超过仅根据体外游离(可透析)部分在体内可扩散的预期速率。含有性激素结合球蛋白和白蛋白的人血清会抑制E1和E2通过子宫毛细血管屏障的流入,而在肝脏中,硫酸E2和葡萄糖醛酸E3的流入量会减少。这些结果与两个器官微血管通透性的差异以及蛋白结合雌激素进入肝脏和子宫的不同可用性相一致。除了几乎完全可扩散到两个器官的E1外,与进入外周器官如子宫相比,雌激素和雌激素结合物进入肝脏的流入量大大增加。